Evaluation of tuberculosis associated chronic pulmonary disease at community health care: a case control study

Authors

  • Chandan Sharma Department of Medicine, Sub-District Hospital, Akhnoor, Jammu, Jammu and Kashmir, India
  • Ashima Badyal Department of Biochemistry, Government Medical College, Jammu, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20211926

Keywords:

Chronic obstructive pulmonary disease, Tuberculosis, Smoking, Hemoptysis

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is known to occur in patients with previous history of pulmonary TB. It is still not very well known if there is any difference of clinical presentation between smoking related COPD or/and TB associated COPD.  

Methods: The present case control study was conducted at CHC Katra, Department of Medicine, over a period of 6 months from August 2018 to February 2018, on 100 patients; 50 suffering from COPD and 50 healthy individuals. Detailed clinical history for duration of symptoms, previous hospitalizations, and exposure to smoking along with the history of TB and ATT courses was recorded.

Results: History of TB was found in 17 patients among cases and 7 patients among controls. In TB associated COPD, the pack years of smoking in case of smokers was 22.4±19.2. 44% (15/34) having exposure to smoking had history of TB. Mean age of patients exposed to smoking was (53.3±7.4) and that of non-smokers (60.1±8.2). A positive correlation with age, BMI, and duration of symptoms was found. Our results showed that almost one-third of COPD patients (34%) had history of TB. TB-associated COPD patients had similar symptoms in our study except for high frequency of hemoptysis.

Conclusions: A detailed population survey is needed on COPD patients with history of TB. A larger group study among never-smokers is also needed. Finally, it is concluded that the case burden of TB associated COPD is real, huge and an urgent policy decision in this regard is mandated.

Author Biographies

Chandan Sharma, Department of Medicine, Sub-District Hospital, Akhnoor, Jammu, Jammu and Kashmir, India

Physician, Department of Medicine, Sub-District Hospital, Akhnoor, Distt. Jammu, J&K, India

Ashima Badyal, Department of Biochemistry, Government Medical College, Jammu, Jammu and Kashmir, India

Lecturer, Department of Biochemistry, Government Medical College, Jammu, J&K, India

References

Rajkumar P, Pattabi K, Vadivoo S, Bhome A, Brashier B, Bhattacharya P, et al. A cross-sectional study on prevalence of chronic obstructive pulmonary disease (COPD) in India: rationale and methods. BMJ Open. 2017;7(5):15211.

Aggarwal D, Gupta A, Janmeja AK, Bhardwaj M. Evaluation of tuberculosis-associated chronic obstructive pulmonary disease at a tertiary care hospital: A case-control study. Lung India. 2017;34(5):415-9.

Sarkar M, Bhardwaz R, Madabhavi I, Modi M. Physical signs in patients with chronic obstructive pulmonary disease. Lung India. 2019;36(1):38-47.

Athanazio R. Airway disease: similarities and differences between asthma, COPD and bronchiectasis. Clinics (Sao Paulo). 2012;67(11):1335-43.

Birath G, Caro J, Malmberg R, Simonsson BG. Airways obstruction in pulmonary tuberculosis. Scand J Respir Dis. 1966;47(1):27-36.

Plit ML, Anderson R, Rensburg CE, Page SL, Blott JA, Fresen JL, et al. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J. 1998;12(2):351-6.

Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86(1):76-85.

Chakrabarti B, Calverley PM, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2007;2(3):263-72.

Huber MB, Kurz C, Kirsch F, Schwarzkopf L, Schramm A, Leidl R. The relationship between body mass index and health-related quality of life in COPD: real-world evidence based on claims and survey data. Respir Res. 2020;21(1):291.

Ramakrishna R, Kumar PVK. Tuberculosis airway disease and bronchiectasis- a debilitatingtrio. J. Evid. Based Med. Healthc. 2016;3(20):818-22.

Lee CH, Lee MC, Lin HH, Shu CC, Wang JY, Lee LN, et al. Pulmonary tuberculosis and delay in anti-tuberculous treatment are important risk factors for chronic obstructive pulmonary disease. PLoS One. 2012;7(5):37978.

Willcox PA, Ferguson AD. Chronic obstructive airways disease following treated pulmonary tuberculosis. Respir Med. 1989;83(3):195-8.

Menezes AM, Hallal PC, Perez PR, Jardim JR, Muino A, Lopez MV, et al. Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America. Eur Respir J. 2007;30(6):1180-5.

Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009;374(9691):733-43.

Downloads

Published

2021-05-25

How to Cite

Sharma, C., & Badyal, A. (2021). Evaluation of tuberculosis associated chronic pulmonary disease at community health care: a case control study. International Journal Of Community Medicine And Public Health, 8(6), 2792–2795. https://doi.org/10.18203/2394-6040.ijcmph20211926

Issue

Section

Original Research Articles